The paracrine effects of mesenchymal stem cells stimulate the regeneration capacity of endogenous stem cells in the repair of a bladder-outlet-obstruction- induced overactive bladder

Stem Cells and Development

Volumn 23, Issue 6, 2014, Pages 654-663

  Song, Miho ^a   Heo, Jinbeom ^a   Chun, Ji Youn ^a   Bae, Hee Sook ^a   Kang, Jeong Wook ^a   Kang, Hyunsook ^a   Cho, Yong Mee ^a   Kim, Seong Who ^a   Shin, Dong Myung ^a   Choo, Myung Soo ^a  

^a University of Ulsan College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; OCTAMER TRANSCRIPTION FACTOR 4; PLATELET DERIVED GROWTH FACTOR; SOLIFENACIN; STROMAL CELL DERIVED FACTOR 1;

ADIPOSE DERIVED STEM CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLADDER NECK STENOSIS; BLADDER SURGERY; CELL MIGRATION; CELL REGENERATION; CONTROLLED STUDY; DISEASE MARKER; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; MESENCHYMAL STEM CELL; MESENCHYMAL STEM CELL TRANSPLANTATION; MUSCLE HYPERTROPHY; NONHUMAN; OVERACTIVE BLADDER; PARACRINE SIGNALING; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; ANIMAL; CELL MOTION; CYTOLOGY; DISEASE MODEL; MESENCHYMAL STROMA CELL; PHYSIOLOGY; REGENERATION; SPRAGUE DAWLEY RAT; URINARY BLADDER, OVERACTIVE;

ANIMALS; CELL MOVEMENT; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; PARACRINE COMMUNICATION; PLURIPOTENT STEM CELLS; RATS; RATS, SPRAGUE-DAWLEY; REGENERATION; URINARY BLADDER, OVERACTIVE;

EID: 84895749684     PISSN: 15473287     EISSN: 15578534     Source Type: Journal    
DOI: 10.1089/scd.2013.0277     Document Type: Article

References (38)

1. Michel M and C. Chapple. (2009). Basic mechanisms of urgency: Roles and benefits of pharmacotherapy. World J Urol 27:705-709.
2. Steers WD. (2002). Pathophysiology of overactive bladder and urge urinary incontinence. Rev Urol 4 Suppl 4:S7-S18.
3. Chu FM and R. Dmochowski. (2006). Pathophysiology of overactive bladder. Am J Med 119:3-8.
4. Andersson K-E. (2011). Antimuscarinic mechanisms and the overactive detrusor: An update. Eur Urol 59:377-386.
5. Fowler CJ. (2002). Bladder afferents and their role in the overactive bladder. Urology 59:37-42.
6. Chapple CR and C.G. Roehrborn. (2006). A shifted paradigm for the further understanding, evaluation, and treatment of lower urinary tract symptoms in men: Focus on the bladder. Eur Urol 49:651-659.
7. Austin JC, S.K. Chacko, M. DiSanto, D.A. Canning and S.A. Zderic. (2004). A male murine model of partial bladder outlet obstruction reveals changes in detrusor morphology, contractility and Myosin isoform expression. J Urol 172: 1524-1528.
8. Peters CA, M.R. Freeman, C.A. Fernandez, J. Shepard, D.G. Wiederschain and M.A. Moses. (1997). Dysregulated proteolytic balance as the basis of excess extracellular matrix in fibrotic disease. Am J Physiol 272:R1960-R1965.
9. Azadzoi KM, T. Tarcan, R. Kozlowski, R.J. Krane and M.B. Siroky. (1999). Overactivity and structural changes in the chronically ischemic bladder. J Urol 162:1768-1778.
10. Abrams P and K-E Andersson. (2007). Muscarinic receptor antagonists for overactive bladder. BJU Int 100:987-1006.
11. Herbison P, J. Hay-Smith, G. Ellis and K. Moore. (2003). Effectiveness of anticholinergic drugs compared with placebo in the treatment of overactive bladder: Systematic review. BMJ 326:841-844.
12. Chapple CR, V. Khullar, Z. Gabriel, D. Muston, C.E. Bitoun and D. Weinstein. (2008). The effects of antimuscarinic treatments in overactive bladder: An update of a systematic review and meta-Analysis. Eur Urol 54:543-562.
13. Wezel F, J. Southgate and D.F. Thomas. (2011). Regenerative medicine in urology. BJU Int 108:1046-1065.
14. Zhao W, C. Zhang, C. Jin, Z. Zhang, D. Kong, WXu and Y. Xiu. (2011). Periurethral injection of autologous adipose-derived stem cells with controlled-release nerve growth factor for the treatment of stress urinary incontinence in a rat model. Eur Urol 59:155-163.
15. Huang Y-C, A.W. Shindel, H. Ning, G. Lin, A.M. Harraz, G. Wang, M. Garcia, T.F. Lue and C-S Lin. (2010). Adipose derived stem cells ameliorate hyperlipidemia associated detrusor overactivity in a rat model. J Urol 183:1232-1240.
16. Zhang H, X. Qiu, A.W. Shindel, H. Ning, L. Ferretti, X. Jin, G. Lin, C.S. Lin and T.F. Lue. (2012). Adipose tissue-derived stem cells ameliorate diabetic bladder dysfunction in a type II diabetic rat model. Stem Cells Dev 21:1391-1400.
17. Montzka K and A. Heidenreich. (2010). Application of mesenchymal stromal cells in urological diseases. BJU Int 105: 309-312.
18. Cheng AS and T.M. Yau. (2008). Paracrine effects of cell transplantation: Strategies to augment the efficacy of cell therapies. Semin Thorac Cardiovasc Surg 20:94-101.
19. Maltais S, J. Tremblay, L. Perrault and H. Ly. (2010). The paracrine effect: Pivotal mechanism in cell-based cardiac repair. J Cardiovasc Transl Res 3:652-662.
20. Gharaibeh B, M. Lavasani, J. Cummins and J. Huard. (2011). Terminal differentiation is not a major determinant for the success of stem cell therapy-cross-Talk between muscle-derived stem cells and host cells. Stem Cell Res Ther 2:31.
21. Lin C-S. (2011). Stem cell therapy for the bladder-where do we stand? J Urol 185:779-780.
22. Lin C-S and T. Lue. (2011). Adipose-derived stem cells: Characterization and application in urology. In: Adipose Stem Cells and Regenerative Medicine. Y-G Illouz and A. Sterodimas, eds. Springer, Berlin, Heidelberg, Germany, pp 193-207.
23. Lin C-S and T. Lue. (2012). Adipose-derived stem cells: Therapy through paracrine actions. In: Stem Cells and Cancer Stem Cells, Volume 4. MA Hayat, ed. Springer, Dordrecht, Netherlands, pp 203-216.
24. Shin DM, E.K. Zuba-Surma, W. Wu, J. Ratajczak, M. Wysoczynski, M.Z. Ratajczak and M. Kucia. (2009). Novel epigenetic mechanisms that control pluripotency and quiescence of adult bone marrow-derived Oct4 (+) very small embryonic-like stem cells. Leukemia 23:2042-2051.
25. Corpechot C, V. Barbu, D. Wendum, N. Chignard, C. Housset, R. Poupon and O. Rosmorduc. (2002). Hepatocyte growth factor and c-Met inhibition by hepatic cell hypoxia: A potential mechanism for liver regeneration failure in experimental cirrhosis. Am J Pathol 160:613-620.
26. Morikawa S, Y. Mabuchi, Y. Kubota, Y. Nagai, K. Niibe, E. Hiratsu, S. Suzuki, C. Miyauchi-Hara, N. Nagoshi, et al. (2009). Prospective identification, isolation, and systemic transplantation of multipotent mesenchymal stem cells in murine bone marrow. J Exp Med 206:2483-2496.
27. Phipps MC, Y. Xu and S.L. Bellis. (2012). Delivery of plateletderived growth factor as a chemotactic factor for mesenchymal stem cells by bone-mimetic electrospun scaffolds. PLoS One 7:e40831.
28. Ratajczak MZ, C.H. Kim, W. Wojakowski, A. Janowska-Wieczorek, M. Kucia and J. Ratajczak. (2010). Innate immunity as orchestrator of stem cell mobilization. Leukemia 24:1667-1675.
29. Ratajczak MZ, E. Zuba-Surma, M. Kucia, R. Reca, W. Wojakowski and J. Ratajczak. (2006). The pleiotropic effects of the SDF-1-CXCR4 axis in organogenesis, regeneration and tumorigenesis. Leukemia 20:1915-1924.
30. Tsuzuki Y, D. Fukumura, B. Oosthuyse, C. Koike, P. Carmeliet and R.K. Jain. (2000). Vascular endothelial growth factor (VEGF) modulation by targeting hypoxia-inducible factor-1{{alpha}} {/} hypoxia response element {/} VEGF cascade differentially regulates vascular response and growth rate in tumors. Cancer Res 60:6248-6252.
31. Ratajczak MZ, R. Reca, M. Wysoczynski, J. Yan and J. Ratajczak. (2006). Modulation of the SDF-1-CXCR4 axis by the third complement component (C3)-implications for trafficking of CXCR4 + stem cells. Exp Hematol 34: 986-995.
32. Ratajczak MZ, H. Lee, M. Wysoczynski, W. Wan, W. Marlicz, M.J. Laughlin, M. Kucia, A. Janowska-Wieczorek and J. Ratajczak. (2010). Novel insight into stem cell mobilizationplasma sphingosine-1-phosphate is a major chemoattractant that directs the egress of hematopoietic stem progenitor cells from the bone marrow and its level in peripheral blood increases during mobilization due to activation of complement cascade/membrane attack complex. Leukemia 24:976-985.
33. Kim CH, W. Wu, M. Wysoczynski, A. Abdel-Latif, M. Sunkara, A. Morris, M. Kucia, J. Ratajczak and M.Z. Ratajczak. (2012). Conditioning for hematopoietic transplantation activates the complement cascade and induces a proteolytic environment in bone marrow: A novel role for bioactive lipids and soluble C5b-C9 as homing factors. Leukemia 26:106-116.
34. Ball SG, C.A. Shuttleworth and C.M. Kielty. (2010). Plateletderived growth factor receptors regulate mesenchymal stem cell fate: Implications for neovascularization. Exp Opin Biol Ther 10:57-71.
35. Ratajczak MZ, B. Machalinski, W. Wojakowski, J. Ratajczak and M. Kucia. (2007). A hypothesis for an embryonic origin of pluripotent Oct-4 (+) stem cells in adult bone marrow and other tissues. Leukemia 21:860-867.
36. Kucia M, R. Reca, F.R. Campbell, E. Zuba-Surma, M. Majka, J. Ratajczak and M.Z. Ratajczak. (2006). A population of very small embryonic-like (VSEL) CXCR4 (+) SSEA-1 (+) Oct-4 (+) stem cells identified in adult bone marrow. Leukemia 20:857-869.
37. Wojakowski W, M. Tendera, M. Kucia, E. Zuba-Surma, E. Paczkowska, J. Ciosek, M. Halasa, M. Krol, M. Kazmierski, et al. (2009). Mobilization of bone marrow-derived Oct-4 (+) SSEA-4(+) very small embryonic-like stem cells in patients with acute myocardial infarction. J Am Coll Cardiol 53:1-9.
38. Lin CS, G. Lin and T.F. Lue. (2012). Allogeneic and xenogeneic transplantation of adipose-derived stem cells in immunocompetent recipients without immunosuppressants. Stem Cells Dev 21:2770-2778.